About
SHANMU, founded in 2021 in London, United Kingdom, is a leading AGI medical robotics company specializing in "unobtrusive" and "continuous monitoring" for the prediction, diagnosis, and management of chronic diseases. Leveraging microfluidic chipsets, multispectral systems, and AI disease models, SHANMU provides digital healthcare solutions for individuals, families, and medical institutions.
The founding team members are graduates from top universities both domestically and internationally, including UCLA, Georgia Tech, Tsinghua University, Fudan University, Johns Hopkins University, and the University of Manchester. Additionally, the team includes researchers and scientists from Google headquarters in the United States, Imperial College London, and Columbia University Medical Center.
SHANMU Vision
Managing over a billion chronic disease patients worldwide, including those with prediabees, hyperuricemia,and chronic nephritisis a vast and critical field. Our solution and their family's health at home. ltenables users to seamlessly manage their own, offers continuous, unobtrusive, and non-invasive monitoring for medication dosage ald chronic disease management, ensuring a better quality of life.
